| __timestamp | Amphastar Pharmaceuticals, Inc. | Intra-Cellular Therapies, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 159205000 | 21226345 |
| Thursday, January 1, 2015 | 174172000 | 139626 |
| Friday, January 1, 2016 | 150976000 | 93831530 |
| Sunday, January 1, 2017 | 149380000 | 79419009 |
| Monday, January 1, 2018 | 187681000 | 368673 |
| Tuesday, January 1, 2019 | 190434000 | 477121 |
| Wednesday, January 1, 2020 | 206506000 | 1895029 |
| Friday, January 1, 2021 | 238029000 | 8034589 |
| Saturday, January 1, 2022 | 250127000 | 20443000 |
| Sunday, January 1, 2023 | 293274000 | 33745000 |
Infusing magic into the data realm
In the competitive landscape of biopharmaceuticals, understanding cost structures is crucial. Amphastar Pharmaceuticals, Inc. and Intra-Cellular Therapies, Inc. offer a fascinating comparison. Over the past decade, Amphastar's cost of revenue has consistently outpaced Intra-Cellular's, peaking in 2023 with a 47% increase from 2014. In contrast, Intra-Cellular Therapies, Inc. saw a dramatic rise in 2016, with costs surging by over 6,600% compared to the previous year, reflecting its growth phase. Despite this, Amphastar's costs remained approximately 8 times higher on average, highlighting its larger scale of operations. This data, spanning from 2014 to 2023, underscores the differing strategies and market positions of these two companies. As the biopharma industry evolves, such insights are invaluable for investors and analysts alike.
Cost of Revenue Trends: Novartis AG vs Amphastar Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Amgen Inc. and Amphastar Pharmaceuticals, Inc.
Cost of Revenue Comparison: Sanofi vs Intra-Cellular Therapies, Inc.
Cost of Revenue Trends: Neurocrine Biosciences, Inc. vs Amphastar Pharmaceuticals, Inc.
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Insmed Incorporated's Expenses
Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: Intra-Cellular Therapies, Inc. vs HUTCHMED (China) Limited
Intra-Cellular Therapies, Inc. vs Wave Life Sciences Ltd.: Efficiency in Cost of Revenue Explored
Intra-Cellular Therapies, Inc. or Amphastar Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Insights: Breaking Down BioMarin Pharmaceutical Inc. and Amphastar Pharmaceuticals, Inc.'s Expenses
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Comparison: ADMA Biologics, Inc. vs Amphastar Pharmaceuticals, Inc.